Mark S Shearman is EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Editas Medicine, Inc.
15 Feb 23
4
Editas Medicine, Inc.
16 Jun 22
4
Editas Medicine, Inc.
11 Feb 22
4
Editas Medicine, Inc.
23 Dec 21
4
Editas Medicine, Inc.
16 Jun 21
3
Editas Medicine, Inc.
16 Jun 21
4
APPLIED GENETIC TECHNOLOGIES CORP
18 Aug 20
4
APPLIED GENETIC TECHNOLOGIES CORP
7 Aug 20
4
APPLIED GENETIC TECHNOLOGIES CORP
19 Aug 19
4
APPLIED GENETIC TECHNOLOGIES CORP
18 Dec 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Feb 23 | EDIT Editas Medicine | Common Stock | Sell | Dispose S | No | No | 9.6653 | 2,790 | 26.97 k | 65,559 |